UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

30 Jun 2014

New real-life and clinical data presented on VIMPAT® (lacosamide) at the 11th ECE

Read More
25 Jun 2014

Multiple data presentations at leading European epilepsy congress highlight UCB’s commitment to advancing epilepsy research

Read More
24 Jun 2014

Acquisition of own shares

Read More
16 Jun 2014

EIB and UCB partnering to accelerate development of new medicines for patients

Read More
13 Jun 2014

First phase 3 study evaluating Cimzia® (certolizumab pegol) in early rheumatoid arthritis presented at EULAR 2014

Read More
12 Jun 2014

New long-term data on Cimzia® (certolizumab pegol) presented at EULAR 2014 shows sustained outcomes in patients with spondyloarthritis

Read More

Stay up-to-date on the latest news and information from UCB